Probiodrug
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Wienberweg 22, Halle, Saxony-Anhalt, 061...Phone Number
+49 493455559900Website
www.probiodrug.deRevenue
<$5 MillionStock Symbol
PBDIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Probiodrug
Headquartered in Halle (Saale), Germany, Probiodrug AG (Euronext Amsterdam: PBD) is a clinical stage biopharmaceutical company focused on the development of new therapeutic products for the treatment of Alzheimer's disease (AD). Probiodrug has identified a new therapeutic concept linked to disease initiation and progression. The development approaches are targeting a key neuro-/synaptotoxic component of the pathology, pyroglutamate-Abeta (pGlu-Abeta) as a therapeutic strategy. Its lead product, PQ912, has successfully completed a Phase 2a (SAPHIR) study. The company's pipeline also includes PBD-C06, an anti-pGlu-Abeta-specific monoclonal antibody, in preclinical development.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Probiodrug your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Probiodrug launches new products
Check out if Probiodrug is spiking on competitors!
Funding: Get notified immidiatlly once Probiodrug has new funding data
Earning: See what the market has to say on Probiodrug recently announced quarterly report
Click to see if Probiodrug had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Probiodrug, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Probiodrug has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Probiodrug
Recommended Actions
Find VP level buyers at Probiodrug
Find 2 more new buyers
Company Profile Activity
Activity Insights
Probiodrug is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Probiodrug is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Probiodrug.
Probiodrug financials insights
Gather financial insights about Probiodrug, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Stock Offering
$28.7M
Probiodrug News & Media
Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation Act
Probiodrug AG: Loss announcement according to §92 paragraph 1 of the German Stock Corporation ActProbiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and Strategy
Probiodrug Appoints Dr. Michael Schaeffer as Executive Vice President of Business and StrategyProbiodrug Reports Financial Results for H1 2018 and Corporate Update
Probiodrug Reports Financial Results for H1 2018 and Corporate Update
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Probiodrug
Sign Up For FreeTo access detailed company insights
Headquartered in Halle (Saale), Germany, Probiodrug AG (Euronext Amsterdam: PBD) is a clinical stage biopharmaceutical company focused on the development of new therapeutic products for the treatment of Alzheimer's disease (AD). Probiodrug has identified a new therapeutic concept linked to disease initiation and progression. The development approac... Read More
